TherapeuticsMD
TXMD
#10760
Rank
โ‚น1.97 B
Marketcap
โ‚น170.89
Share price
-1.64%
Change (1 day)
61.87%
Change (1 year)

EPS for TherapeuticsMD (TXMD)

EPS in 2026 (TTM): โ‚น7.06

According to TherapeuticsMD's latest financial reports the company's current EPS (TTM) is โ‚น7.60. In 2021 the company made an earnings per share (EPS) of -โ‚น2,060 an increase over its 2020 EPS that were of -โ‚น3,180.

EPS history for TherapeuticsMD from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น7.06
2021-โ‚น2,060-35.22%
2020-โ‚น3,180-5.63%
2019-โ‚น3,37020.34%
2018-โ‚น2,80155.26%
2017-โ‚น1,804-19.15%
2016-โ‚น2,231-6%
2015-โ‚น2,37442.86%
2014-โ‚น1,66152.17%
2013-โ‚น1,092

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น72.15 850.00%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น338.98 4,363.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Agile Therapeutics
AGRX
-โ‚น367.42-4,937.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
โ‚น178.09 2,244.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lannett Company
LCI
-โ‚น2,400-31,700.00%๐Ÿ‡บ๐Ÿ‡ธ USA